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Abstract
Background: New approaches to cope with clinical and psychosocial aspects of type 2 diabetes (T2DM) are
needed; gender influences the complex interplay between clinical and non-clinical factors. We used data from the
BENCH-D study to assess gender-differences in terms of clinical and person-centered measures in T2DM.
Methods: Clinical quality of care indicators relative to control of HbA1c, lipid profile, blood pressure, and BMI were
derived from electronic medical records. Ten self-administered validated questionnaires (SF-12 Health Survey; WHO-5
well-being index; Problem Areas in Diabetes (PAID) 5, Health Care Climate Questionnaire, Patients Assessment of
Chronic Illness Care, Diabetes Empowerment Scale, Diabetes Self-care Activities, Global Satisfaction for Diabetes
Treatment, Barriers to Taking Medications, Perceived Social Support) were adopted as person-centered outcomes
indicators.
Results: Overall, 26 diabetes clinics enrolled 2,335 people (men: 59.7%; women: 40.3%). Lower percentages of women
reached HbA1c levels < =7.0% (23.2% vs. 27.8%; p = 0.03), LDL-cholesterol < 100 mg/dl (48.3 vs. 57.8%; p = 0.0005), and
BMI <27 Kg/m2 (27.2 vs. 31.6%; p = 0.04) than men. Women had statistically significant poorer scores for physical
functioning, psychological well-being, self-care activities dedicated to physical activities, empowerment, diabetes-related
distress, satisfaction with treatment, barriers to medication taking, satisfaction with access to chronic care and healthcare
communication, and perceived social support than men; 24.8% of women and 8.8% of men had WHO-5 < =28 (likely
depression) (p < 0.0001); 67.7% of women and 55.1% of men had PAID-5 > 40 (high levels of diabetes-related distress) (p
< 0.0001). At multivariate analysis, factors associated with an increased likelihood of having elevated HbA1c levels (≥8.0%)
were different in men and women, e.g. having PAID-5 levels >40 was associated with a higher likelihood of HbA1c ≥8.0%
in women (OR = 1.15; 95%CI 1.05–1.25) but not in men (OR = 1.00; 95%CI 0.93–1.08).
Conclusions: In T2DM, women show poorer clinical and person-centered outcomes indicators than men. Diabetes-
related distress plays a role as a correlate of metabolic control in women but not in men. The study provides new
information about the interplay between clinical and person-centered indicators in men and women which may guide
further improvements in diabetes education and support programs.
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Background
The considerable pressure on health care systems to
provide high-quality care while controlling costs has led
several public and private health care organizations to
promote initiatives to measure and improve the quality
of care for people with diabetes [1, 2].
In Italy, the Associazione Medici Diabetologi (AMD)
scientific society has implemented since 2006 a continu-
ous improvement effort involving a large network of dia-
betes clinics throughout the country (AMD-Annals) [3].
The periodic dissemination of Annals has been effective
in improving several process and intermediate outcome
indicators clinical indicators over a few years [4]. The
model has also been proven to be cost-effective [5].
Data from AMD-Annals have been recently used to
evaluate gender differences in pharmacological and non-
pharmacological treatment of diabetes [6]. The analysis
was important to demonstrate that gender disparities are
less pronounced in Italy than in other countries, but that
the likelihood to reach specific clinical outcomes is sys-
tematically unfavorable for women as compared to men;
in particular, women were 14% more likely than men to
have HbA1c levels >9.0% in spite of insulin treatment,
42% more likely to have LDL-cholesterol ≥130 mg/dl in
spite of lipid-lowering treatment, and 50% more likely to
have BMI ≥30 Kg/m2. These findings suggested that a
complex interplay among biological, clinical and behav-
ioral differences can underlie these differences and call
for diversifying the care and specializing the support
provided to men and women.
In parallel, the increasing recognition of patient-
centered care as the best model to ensure a care respect-
ful of, and responsive to patient preferences, needs, and
values [7] call for the need to include psychosocial as-
pects in the quality model of diabetes care, as clearly
emphasized by the international Diabetes Attitudes,
Wishes, and Needs (DAWN-2) Program [8]. The
DAWN-2 study well documented that people with dia-
betes have major psychosocial issues; in particular, 44.6%
(country range 17.2–67.6%) of people with diabetes have
diabetes-related distress (i.e. Problem Areas in Diabetes
Scale 5 (PAID-5) score ≥ 40) [9], while 13.8% have
likely depression [WHO-5 Well-Being Index (WHO-5)
score ≤ 28] [10] (country range 6.5–24.1%). Furthermore,
diabetes had a negative impact on physical health and
social relationship; approximately 40% of participants
reported that their medication interfered with their ability
to live a normal life.
Due to this body of evidence, individualized interven-
tions based on patient needs, concerns, and capabilities
have been promoted while taking gender into account.
In the context of the AMD-Annals and the DAWN2
initiatives, the BENCH-D study (Benchmarking Network
for Clinical and Humanistic Outcomes in Diabetes) was
launched aiming to test a model of regional benchmark-
ing to monitor and improve not only clinical indicators,
but also person-centered outcomes [11]. Besides the
AMD clinical indicators for the evaluation of quality of
care, the BENCH-D study used validated questionnaires,
largely derived from the DAWN2 study, for measuring
person-centered dimensions.
The first important step of the BENCH- study was to
describe the person-centered indicators in type 2 popu-
lation and to explore the relationship among different
quality of care and quality of life dimensions. As de-
scribed in two previous papers [12, 13], BENCH-D doc-
umented that: high levels of diabetes distress are
common among people with type 2 diabetes (T2DM),
affecting almost two-thirds of patients; high diabetes dis-
tress is associated with worse clinical and psychosocial
outcomes; higher empowerment is on the other hand as-
sociated with better glycemic control, psychosocial func-
tioning and perceived access to person-centered chronic
illness care.
In the present secondary analysis of the BENCH-D
data, database has been used to assess gender-
differences in T2DM in terms of diabetes-related dis-
tress, physical and psychological well-being, empower-
ment, perceived social support and other measures of
satisfaction with treatment and care. We wanted to test
the hypothesis that systematic differences exist in the
two genders in the interplay between clinical and
person-centered indicators, especially on the likelihood
on poor metabolic control (i.e. HbA1c > =8.0%). A dee-
per comprehension of these differences may inform indi-
vidualized, gender-specific educational approaches.
Methods
A detailed description of the BENCH-D study protocol
and of the questionnaires utilized as person-centered in-
dicators was published elsewhere [11]. Briefly, a random
sample of patients with T2DM stratified by diabetes
treatment (oral agents, insulin + oral agents, insulin) was
selected by 26 diabetes outpatient clinics in Italy.
Following the AMD-Annals methodology [3–6], clin-
ical data were extracted from electronic databases of dia-
betes clinics, including information on body mass index
(BMI), diabetes duration, HbA1c, blood pressure and
lipid profile values, glucose-lowering, antihypertensive
and lipid-lowering treatments, diabetic complications
(i.e. retinopathy, diabetic nephropathy, foot complica-
tions, and previous cardiovascular and cerebrovascular
events). AMD-Annals intermediate outcome measures
were evaluated on the BENCH-D sample; these indica-
tors include the proportion of patients with satisfactory
values as well as the percentage of those with unaccept-
ably high values. Outcomes were considered satisfactory
if HbA1c levels were ≤7.0% (≤53 mmol/mol), blood
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pressure values were ≤130/80 mmHg, LDL cholesterol
(LDL-c) levels were <100 mg/dl, and BMI was <27 Kg/
m2. Unsatisfactory outcomes include HbA1c levels
>8.0%, blood pressure values ≥140/90 mmHg, LDL levels
≥130 mg/dl, and BMI ≥30 Kg/m2 [6].
Information on socio-demographic characteristics,
quality of life, satisfaction, and self-care behaviors and
attitudes was collected using an ad hoc self-administered
questionnaire including ten validated instruments
which are described in Table 1 [9, 10, 14–32]. The
scores of these instruments represented the person-
centered outcomes. In line with the methodology
applied in the DAWN2 study [8], the instruments were
chosen to evaluate the impact of diabetes and its man-
agement on physical and psychological well-being and
satisfaction. In addition, perceived barriers, diabetes
distress, and social support were included as mediators
of the relationship between self-care activities, quality
of life, and diabetes outcomes. All the instruments
were validated and showed satisfactory psychometric
properties [9].
All the scores (i.e. person-centered indicators) ranged
between 0 and 100, with higher values indicating higher
levels of the dimension investigated. The only exception
is the SDSCA6 scale [27] that provides a single score for
each item, ranging from 0 to 7 to indicate the average
Table 1 Questionnaires used and validated in the BENCH-D study
Questionnaire Abbreviation Domain Brief description No. of
items
Scoring References
SF-12 Health Survey -
physical component
SF-12 PCS Physical functioning SF-12 is a widely used generic health status measure.
It includes 12 items which can be aggregated into
two summary measures: the Physical (PCS) and Mental
(MCS) Component Summary scores. Both scores range
from 0 (worst possible health state) to 100 (best possible
health state); they are normalized to a general population






WHO-5 assesses the psychological well-being, a core
component of overall quality of life. It is also a valid
and reliable risk assessment measure for mild, moderate
and severe depression. A score <50 indicates poor
psychological well-being, a score <=28 indicates probable
depression.
5 0-100 [10, 15]
Problem Areas in
Diabetes
PAID-5 Diabetes distress PAID-5 evaluates diabetes related emotional distress, i.e.
specific worries and negative emotions related to diabetes.
A score >40 indicates high diabetes-related distress.






HCC-SF evaluates the extent to which clinicians tend to
favor the autonomy of the patient or, instead, tend to
assume a paternalistic attitude towards the patient. Higher
scores correspond to a higher perception by the patient
of autonomy support.
6 0-100 [21, 22]
Patients Assessment
of Chronic Illness
Care - Short Form
PACIC-SF Quality of chronic
illness care and
patient support
PACIC provides an assessment of patient perceived access
to support from the health care team according to a
chronic care health delivery model. The higher the score
the more favorable the patient experience.
11 0-100 [23, 24]
Diabetes
Empowerment




DES-SF assesses the patient’s confidence in taking an active
role in own management of the condition. The higher the
score the higher the patient empowerment
8 0-100 [25, 26]
Diabetes Self-care
Activities
SDSCA-6 Self-care activities SDSCA-6 assesses self-reported health behaviors related
to diet, physical activity, self-monitoring of blood glucose,







GSDT assesses overall satisfaction with the medical diabetes
treatment, here under the perceived impact of medication
on daily life and psychological well being, The higher the




BM Barriers to taking
medication
BM assesses what concrete barriers patients feel they face
in daily life to taking their medication as scheduled. The






PSS assesses satisfaction with social support from various
sources for managing diabetes (healthcare system,
community, family, peers…). The higher the score the
higher the perceived support.
5 0-100 [29–32]
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number of days in the previous week respondent had
performed each self-care activity. Two dichotomous
person-centered indicators were also utilized: percentage
of people with WHO-5 < =28 indicating likely depression
[10, 15], and percentage of people with PAID-5 > 40 in-
dicating high diabetes-related distress [9, 16–20].
All the clinical and person-centered data collected in
the study have been anonymized and centrally analyzed.
Local ethics committees of all participating centers ap-
proved the protocol.
Statistical analysis
No formal sample size estimation was performed. Each
center was required to enroll up to 100 patients.
Differences in socio-demographic characteristics,
clinical outcomes and in mean quality of life/satisfac-
tion scores according to gender were evaluated and
compared using the chi-square tests for categorical
variables and the Mann-Whitney test for continuous
variables. Data were expressed as mean and standard
deviation or frequency. A p-value <0.05 was consid-
ered statistically significant.
Mean scores of questionnaires were also adjusted for
age, diabetes duration, BMI, presence of diabetes com-
plications, glucose-lowering treatment class, school edu-
cation, and living status. Data were expressed as mean
and standard error.
Fully adjusted multivariate logistic models, separated
for men and women, were applied to identify socio-
demographic, clinical and person-centered factors asso-
ciated with the achievement of HbA1c levels ≥8.0% in
the two genders. Results are expressed as Odds Ratios
(ORs) with their 95% confidence intervals (95%CI). All
statistical analyses were performed using SAS 9.4 (The
SAS Institute, Cary, NC, USA),
Results
Between January 2010 and July 2011, 26 diabetes
clinics enrolled 2,390 people with T2DM; information
on gender was available for 2,335 (97.7%); men were
1,393 (59.7%) and women were 942 (40.3%). Popula-
tion characteristics by gender are reported in Table 2:
compared to men, women were slightly older, had a
lower level of school education, and were more likely
to live alone. Women were less frequently smokers
than men. From a clinical point of view, despite a
longer diabetes duration and a higher likelihood to be
treated with insulin, women showed a lower preva-
lence of known diabetes complications than men.
Higher levels of HbA1c, total and LDL-cholesterol
and BMI were found in women and AMD-Annals
intermediate outcome indicators were systematically
less satisfactory in women than in men, with lower
percentages of women reaching favorable therapeutic
goals for HbA1c, lipid profile and BMI than men, and
parallel higher percentages of women with unaccept-
ably high levels of the same parameters (Fig. 1).
Between-gender differences in person-centered in-
dicators are shown in Table 3. Women had statisti-
cally significant poorer scores for physical
functioning, psychological well-being, self-care activ-
ities dedicated to physical activities, empowerment,
diabetes-related distress, satisfaction with treatment,
barriers to medication taking, satisfaction with access
to chronic care and healthcare communication, and
perceived social support than men. On the other
hand, women showed higher adherence than men to
self-care activities dedicated to self-monitoring of
blood glucose and foot monitoring. The comparison
of scores between genders after adjusting for clinical
and socio-demographic characteristics showed that
the difference in empowerment scores was no longer
significant, while all the other differences remain
consistent with the crude scores (Table 3). One in
four women and one in ten men showed likely de-
pression (WHO-5 < =28), while two in three women
and one in two men showed high diabetes-related
distress (PAID-5) (Fig. 2).
In a multivariate analysis, factors associated with an in-
creased likelihood of having elevated HbA1c levels (≥8.0%)
were different in men and women (Table 4). In particular:
– Both in men and in women, insulin treatment alone
or in association with OHAs increased the likelihood
of having HbA1c ≥ 8.0% from 13 to 33% vs.
OHAs only;
– In men but not in women, the likelihood of having
HbA1c ≥ 8.0% decreased as age increased (−3% for
each additional 5 years) and was associated with the
level of school education;
– In women but not in men, high levels of diabetes
related distress were associated with a higher
likelihood of poor metabolic control.
Discussion
Data from the BENCH-D study provide new insights
into the quality of care and quality of life as perceived by
men and women with T2DM. Health related quality of
life represents not only a key outcome of any person-
centered chronic care model, but also an important me-
diator for adherence to treatment and the achievement
of therapeutic goals.
Our data show, in line with the results of AMD-
Annals [6], that women with T2DM have poorer inter-
mediate outcome indicators than men, i.e. higher levels
of HbA1c and poorer control of key cardiovascular risk
factors such as BMI and LDL-cholesterol. Data also
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Table 2 Socio-demographic and clinical characteristics according to gender




Mean age (years) 64.4 (10.0) 66.1 (10.4) <0.0001
Age in classes (%) <55 17.5 14.8 <0.0001
55–65 33.3 27.6
65–75 35.3 37.8
> = 75 13.9 19.7
School education (%) Primary school 30.3 53.4 <0.0001
Middle school 32.7 22.9
High school 28.4 19.8
University 8.6 3.9








Smokers No 33.5 73.2 <0.0001
Yes 20.2 11.4
Ex 46.3 15.5
BMI (Kg/m2) 29.7 (5.9) 31.0 (6.1) <0.0001
Diabetes duration (years) 13.4 (15.1) 15.5 (15.6) 0.006
Mean HbA1c (%) 7.6 (1.5) 7.8 (1.5) 0.002
Total cholesterol (mg/dl) 170.9 (38.1) 187.3 (40.4) <0.0001
LDL cholesterol (mg/dl) 96.9 (31.1) 106.7 (34.4) <0.0001
HDL cholesterol (mg/dl) 46.7 (13.9) 54.1 (14.2) <0.0001
Triglycerides (mg/dl) 142.8 (116.4) 140.0 (100.6) 0.64
Systolic blood pressure (mmHg) 135.1 (15.8) 135.8 (16.8) 0.39
Diastolic blood pressure (mmHg) 78.3 (9.3) 78.2 (8.8) 0.97
Diabetes treatment (%) Oral agents 52.6 44.9 0.001
Oral agents + insulin 23.0 27.2
Insulin 24.3 27.9
Lipid-lowering treatment (%) 48.5 47.6 0.65
Antihypertensive treatment (%) 67.6 70.4 0.16
No. of diabetes complications 0 63.7 70.0 0.0001
1 26.1 23.9
> = 2 10.2 6.2
a χ-square test for categorical variables and the Kruskal-Wallis test for continuous variables
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Fig. 1 Between-gender differences in the intermediate outcomes indicators of AMD-Annals
Table 3 Person-centered indicators in men and women with type 2 diabetes. Crude data are expressed as mean and standard
deviation (std); adjusted data are expressed as mean and standard error (se)
Crude scores Adjusted scores a
Person-centered care indicator Person-centered indicator Men Women p-value Men Women p-value
Mean (std) Mean (std) Mean (se) Mean (se)
Physical functioning SF12 – PCS 44.9 (9.1) 40.3 (9.9) <0.0001 44.0 (0.32) 40.8 (0.37) <0.0001
Psychological well-being WHO-5 62.5 (21.1) 49.5 (23.7) <0.0001 61.2 (0.80) 50.7 (0.96) <0.0001
Self-care activities DSCA-Diet 5.0 (1.9) 5.0 (2.0) 0.79 4.9 (0.07) 5.0 (0.09) 0.26
DSCA-Exe 3.4 (2.6) 2.7 (2.5) <0.0001 3.1 (0.09) 2.7 (0.11) 0.002
DSCA-SMBG 3.8 (2.6) 4.3 (2.5) <0.0001 3.8 (0.09) 4.2 (0.10) 0.004
DSCA-Feet 3.2 (2.8) 3.8 (2.8) <0.0001 3.1 (0.10) 3.9 (0.12) <0.0001
DSCA-Drugs 6.6 (1.4) 6.6 (1.4) 0.89 6.6 (0.05) 6.6 (0.06) 0.88
Empowerment DES 80.3 (15.3) 78.4 (16.2) 0.004 78.5 (0.56) 77.8 (0.66) 0.46
Diabetes distress PAID-5 42.0 (26.9) 51.4 (28.1) <0.0001 41.8 (1.00) 49.4 (1.19) <.0001
Satisfaction with treatment GSDT 80.7 (11.9) 78.8 (12.9) 0.0004 80.8 (0.44) 79.1 (0.53) 0.01
Barriers to medication taking BM 24.4 (9.1) 26.0 (10.5) <0.0001 24.1 (0.33) 25.7 (0.39) 0.003
Experience of access to chronic illness care PACIC 74.8 (15.8) 73.5 (16.5) 0.05 74.3 (0.60) 72.4 (0.71) 0.05
Experience of health care communication HCCQ 88.8 (14.2) 87.4 (15.4) 0.03 88.4 (0.52) 86.9 (0.62) 0.06
Perceived social support PSS 81.1 (15.4) 78.2 (15.1) <0.0001 80.8 (0.52) 77.3 (0.63) <.0001
a adjusted for age, diabetes duration, BMI diabetes complications, glucose-lowering treatment scheme, school education, and living status
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show that, compared to men, women have lower levels
of general well-being, diabetes-related quality of life, sat-
isfaction with treatment and care, self-care attitudes ded-
icated to physical activity, and empowerment. On the
other hand, women report a higher level of adherence to
SMBG and foot monitoring. It has been documented
that SMBG not supported by adequate education to de-
velop skills to modify therapy and behaviors based on
the SMBG readings can worsen quality of life [33].
Our data also show that gender differences in the level
of empowerment are largely dependent on the differ-
ences in the socio-demographic and clinical characteris-
tics, while all the other person-centered indicators
remain less satisfactory in women than in men also after
adjustment for patient case-mix. This suggests that the
lower socioeconomic status of women with T2DM in
our sample was associated with autonomy and informed
decision-making, as well as problem solving and goal
setting (i.e. the areas covered by the DES scale) [34], but
not with the general and diabetes-specific dimensions of
quality of life and patient satisfaction investigated
through all the other questionnaires.
Finally, at multivariate analysis adjusted for all the pa-
tient characteristics, in men the likelihood of poor gly-
cemic control (HbA1c ≥8.0%) was associated with socio-
demographic and clinical characteristics, i.e. age, school
level, and insulin treatment (to be intended as a proxy of
diabetes severity), while in women insulin treatment and
diabetes-related distress, but not socio-demographic
characteristics played a role.
Patients with higher diabetes-related distress put a
greater weight on their disease, which absorbs daily
mental and physical energy. Higher diabetes related
emotional distress levels are associated with lower pa-
tient adherence and empowerment levels [35, 36]. Our
data show that diabetes distress plays a role as a correl-
ate of good metabolic control in women but not in men.
The study suggests that new gender-specific ap-
proaches to cope with clinical and psychosocial aspects
of diabetes may be needed. The interplay among
clinical and non-clinical factors is complex and gen-
der influences the relationship between the different
components.
The existence of gender-specific needs has been sug-
gested by a relevant body of literature and healthcare
systems are increasingly challenged to consider the dif-
ferent health issues of women and men in terms of pre-
vention, clinical signs, therapeutic approach, prognosis,
psychological and social impact [37].
From a mere clinical point of view, a gender-based ap-
proach in the management of T2DM must consider the
different CVD profile of men and women. In fact,
although the overall CVD risk is higher in T2DM men,
the relative risk of coronary heart disease (CHD) is
higher in T2DM women when compared to people with-
out diabetes, with the loss of the typical oestrogen protec-
tion in the premenopausal state [38]. Diabetes is a
powerful cardiovascular risk factor for both genders, but
the relative risk of coronary heart disease deriving from
having T2DM is higher in women than in men [39, 40].
Multiple factors are responsible for these differences, in-
cluding gender-differences in metabolic control, cardio-
vascular risk, and treatments [41, 42], especially disparities
in the routine management of LDL-C levels [43].
From a psychosocial point of view, many differences
exist between men and women in beliefs, attitudes, fears
and concerns about diabetes and its management [44].
In particular, women report significantly more depres-
sive symptoms than men [45], female sex is a predictor
of poor psychological outcomes [46], and depressive
Fig. 2 Between-gender differences in the prevalence of likely depression (WHO-5 < =28) and high diabetes-related distress (PAID-5 > 40)
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Table 4 Factors associated with increased likelihood of poor metabolic control (HbA1c > =8.0%)
Covariates a Categories Men Women
OR 95%CI OR 95%CI
AGE by 5 years 0.97 0.95–0.99 0.98 0.96–1.00
School education High school or university 0.87 0.80–0.95 0.92 0.82–1.03
Middle school 0.95 0.87–1.03 0.94 0.84–1.05
Primary school 1.00 - 1.00 -
Living status Spouse / sons 1.00 - 1.00 -
Alone 0.89 0.77–1.03 1.08 0.97–1.22
Other 1.01 0.88–1.15 1.14 0.93–1.39
Smoker Ex 0.99 0.92–1.07 1.05 0.94–1.17
Yes 0.97 0.89–1.07 1.03 0.89–1.20
No 1.00 - 1.00 -
BMI 0–27.0 0.91 0.84–0.99 0.93 0.84–1.03
27.1–30.0 0.89 0.82–0.97 0.91 0.82–1.01
>30.0 1.00 - 1.00 -
Diabetes duration <=5.0 years 1.31 1.20–1.43 1.33 1.20–1.48
5.1–10.0 years 1.26 1.15–1.38 1.13 1.01–1.26
>10.0 years 1.00 - 1.00 -
Treatment class OHAs + insulin 1.31 1.20–1.43 1.33 1.20–1.48
Insulin only 1.26 1.15–1.38 1.13 1.01–1.26
OHAs only 1.00 - 1.00 -
No. of diabetes complications > = 1 0.94 0.87–1.01 0.94 0.86–1.03
0 1.00 - 1.00 -
SF12 – PCS Tertile 1 1.04 0.95–1.14 0.98 0.88–1.09
Tertile 2 1.01 0.93–1.10 0.93 0.84–1.02
Tertile 3 1.00 - 1.00 -
WHO-5 <=28 1.03 0.92–1.16 1.01 0.92–1.12
>28 1.00 - 1.00 -
DES Tertile 1 1.09 0.99–1.19 1.07 0.96–1.20
Tertile 2 1.00 0.92–1.08 0.91 0.82–1.00
Tertile 3 1.00 - 1.00 -
PAID-5 > 40 Yes 1.00 0.93–1.08 1.15 1.05–1.25
No 1.00 - 1.00 -
GSDT Tertile 1 1.24 0.93–1.65 0.91 0.62–1.33
Tertile 2 1.09 0.99–1.19 1.07 0.96–1.20
Tertile 3 1.00 0.92–1.08 0.91 0.82–1.00
PACIC Tertile 1 1.02 0.93–1.11 0.87 0.77–1.00
Tertile 2 0.94 0.87–1.03 0.92 0.82–1.02
Tertile 3 1.00 - 1.00 -
HCCQ Tertile 1 0.93 0.87–1.00 1.08 0.98–1.18
Tertile 2–3 1.00 - 1.00 -
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symptom severity is associated with poorer diet and
medication regimen adherence [30]. Also, women more
often experience diabetes related distress than men [47].
Recently, Fisher [35] clarified that diabetes distress is not
a proxy for clinical depression but reflects an emotional
response to a demanding health-related condition; con-
versely, major depressive disorder is a psychiatric dis-
order which is not content-related in so far that it does
not describe pathology based on relevant causes, pertur-
bations or contextual stressors. The investigation of dia-
betes related and unrelated stressors should represent an
integral component of ongoing comprehensive care for
all patients with diabetes [35].
Additional elements deriving from previous qualitative
and quantitative studies are that: Women with diabetes
showed less patient satisfaction and a lower health-
related quality of life than men with diabetes [48]; men
are more concerned about how diabetes affects their
provider role [49], whereas women worry more about
how self-care will hinder their familial responsibilities
[50]; women tend to sacrifice their dietary regimen for
their family’s food preferences [51]; men focused on
practical aspects of SMBG whereas women focused on
affective components of SMBG [44]; men find support
from family and friends more helpful than do women
[44]. Disease management programs for people with dia-
betes have been shown to save money and improve out-
comes and it is recognized that they cannot ignore
information about gender-specific differences [52].
In line with the cross-national design of the Diabetes
Attitudes, Wishes and Needs second study (DAWN2™),
BENCH-D study promotes benchmarking using psycho-
metrically validated indicators to identify areas for im-
provement and best practices to drive changes that
improve outcomes for people with diabetes [8]. Gender-
differences in person-centered indicators identified in
this analysis highlight the importance of considering
gender as an important part of further research into
person-centered diabetes care.
The study has strengths and limitations. As main
strength, BENCH-D is the first study allowing a compre-
hensive evaluation of the association between clinical
and person-centered care dimensions in the two gen-
ders, increasing the knowledge about the complex inter-
play among patient characteristics and perceptions.
Main limitations of this analysis is its cross-sectional
nature, that does not allow to establish a cause-effect re-
lationship between clinical and person-centered indica-
tors. However, the longitudinal phase of the BENCH-D
study, focusing on informing quality of care improve-
ments through person-centered outcomes, will allow for
an assessment of the person-centered medicators of
impacts of educational approaches in diabetes care on
clinical and quality of life outcomes.
Finally, the study sample is representative of patients at-
tending diabetes clinics, and results cannot be generalized
to individuals who only attend their general practitioner.
Conclusions
In the BENCH-D study we collected reliable information
about a range of person-centered outcomes such as de-
pression, diabetes-related distress, self-care activities,
empowerment, satisfaction with treatment, barriers to
medication taking, satisfaction with access to chronic
care and healthcare communication, and perceived so-
cial support in routine clinical practice and were able to
identify important gender differences in the impact of
diabetes. Specifically, we found that in T2DM women
show poorer clinical and person-centered outcomes
indicators than men. Diabetes-related distress plays a
role as a correlate of metabolic control in women but
not in men. The study provides new information about
the interplay between clinical and person-centered indi-
cators in men and women which may guide further
improvements in diabetes education and support
programs.
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